Behind every innovation is a committed clinical team.
Ramathibodi Hospital in Bangkok is now live with the CyberKnife® S7™ System—advancing precision cancer care and expanding access to SBRT.
A great milestone for Thailand.
#Oncology#RadiationTherapy#SBRT#CancerCare #HealthcareInnovation
Integrating AlignRT InBore with the Accuray Helical platform underscores a shared focus on advancing flexible, vendor-agnostic solutions that enhance modern treatment workflows.
Congratulations to all involved.
👇See announcement:
We're pleased to announce the first clinical use of AlignRT InBore on the Accuray Helical Platform.
Clinique Générale-Beaulieu is the first center treating patients with this solution, enabling continuous surface-guided monitoring inside Radixact: https://t.co/hVhvx9A6JO
New milestone: Go-Live of a Radixact® System at City Hospital #40 in St. Petersburg.
Expanding access to precise, high-quality radiotherapy through strong collaboration across teams.
Congratulations to all involved.
#AccurayExpandRT#Radiotherapy
📍 We’re live at Booth 8 in Lyon!
The 64th Journées Scientifiques de Physique Médicale is underway, and our team is ready to connect.
Stop by to explore how we’re advancing RT through innovative solutions & real-world clinical insights.
#AccurayExpandRT
Congratulations to @banu_atalar the @iartistanbul team on a successful inaugural symposium! Thanks to Pr Ricardi and Dr Knybel for sharing their vast experience on Accuray technologies. #iartistanbul
"I was impressed with the fact that treatment would be compressed into a short period of time. Rather than months, Don was scheduled for five CyberKnife treatment sessions for his prostate cancer over a period of 10 days.
Learn more about CyberKnife at https://t.co/tR0xv2zqUy
#CyberKnife often called a "Miracle Machine" delivering pinpoint noninvasive radiation therapy, treating tumors almost anywhere in the body in 1 to 5 sessions. Lana Wright from ND shares her story how it saved her life & didn't slow her down 305-279-2900 https://t.co/nJ2Q6dnlQT
Save the Date☝️🏼 Kommender Samstag, 20.06.26 🕐13:55 Uhr Dr. Haidenberger #Cyberknife® Center zeigt wie gut- & bösartige #Tumore heute therapiert werden!
📍Zentrum für Visionen Salzburg
🎟️Eintritt frei
👉🏼Anmeldung 🔗 https://t.co/KWB5jZIEyD
PRIMO MEDICO ℹ️https://t.co/Pl1KFlHvax
📢 Don’t miss our June 25 #AccurayExchange webinar!
Discover 14 years of TomoTherapy® clinical experience at Chiang Mai University with Dr. Nobnop.
Moderated by @LeeGoddard
🔗 Register now: https://t.co/uz3ndLX5Pv
#Radiotherapy#Oncology
#ISRS26 CDI, Milan: retrospective series of 426 pts tx w/ #CyberKnife for trigeminal neuralgia. 👉High rates of sustained pain control (92.7% BNI I–IIIa), stable for mean 47.9 mo, retreatment performed in a subset of patients, low rates of bothersome sensory complications.
#ISRS26 A retrospective analysis of #CyberKnife#Synchrony lung fiducial tracking data from Sir Charles Gairdner Hospital, Australia found a 3 mm isotropic margin to be adequate for central and UC tumours & 5 mm margin for peripheral lesions #Radiotherapy#SBRT#LungCancer
#ISRS26 Carlo Besta Neurological Institute: multi-session RS w/ #CyberKnife for non-functioning pituitary adenoma w/ residual or recurrent disease. No radiological progression, visual function generally preserved, limited toxicity. #Radiotherapy#Radiosurgery#PituitaryAdenoma
According to Dr Francesco Cuccia, ARNAS Civico Hospital in Palermo, Italy, selected patients with isolated peritoneal or abdominal wall metastases may benefit from SBRT. Watch to learn more: https://t.co/XHYNi3A29d #TomoTherapy#Radixact#ESTRO26@ESTRO_RT
#ISRS26 preclinical research from Huashan Hospital, China, suggests enhanced high grade glioma control with induction SRS compared w/ sequential boost. The induction regimen was reported as well tolerated in small pilot study.#CyberKnife#Glioblastoma#NeuroOncology#RadOnc